Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

AP-1 Mediated Transcriptional Repression of Matrix Metalloproteinase-9 by Recruitment of Histone Deacetylase 1 in Response to Interferon β.
Diffusion tensor imaging based network analysis detects alterations of neuroconnectivity in patients with clinically early relapsing-remitting multiple sclerosis.
Heat shock protein 27 in multiple sclerosis relapses.
Quality of Life Assessment in Patients with Multiple Sclerosis Receiving Interferon Beta-1a: A Comparative Longitudinal Study of Avonex and Its Biosimilar CinnoVex.
Fingolimod treatment promotes regulatory phenotype and function of B cells.
Low Dose Naltrexone for Treatment of Multiple Sclerosis: A Retrospective Chart Review of Safety and Tolerability.
Transcranial direct current stimulation (tDCS) for fatigue in multiple sclerosis.
Hypovitaminosis-D and EBV: no interdependence between two MS risk factors in a healthy young UK autumn cohort.
The origins of multiple sclerosis: a synthesis
Non-local robust detection of DTI white matter differences with small databases.
Immunomodulation of fucosyl-lactose and lacto-N-fucopentaose on mononuclear cells from multiple sclerosis and healthy subjects.
A novel anti-EMMPRIN function-blocking antibody reduces T cell proliferation and neurotoxicity: relevance to multiple sclerosis.
Resveratrol effects on astrocyte function: Relevance to neurodegenerative diseases.
Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
Ten-year prognosis in multiple sclerosis: a better outcome in relapsing-remitting patients but not in primary progressive patients.
Exploratory Study to Assess the Effect of Fampridine (BIIB041) on Walking Ability and Balance in Participants With Multiple Sclerosis. (MOBILE)
Epigenetic changes in neurology: DNA methylation in multiple sclerosis.
RORγt-specific transcriptional interactomic inhibition suppresses autoimmunity associated with TH17 cells.
Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre.
Feature Article: Identification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications.
Axoskeletal proteins prevent oligodendrocyte from toxic injury by upregulating survival, proliferation, and differentiation in vitro.
The benefits and detriments of macrophages/microglia in models of multiple sclerosis.
Teva and Active Biotech Announce First Patient Enrolled in Phase II Study Evaluating Laquinimod for Primary Progressive MS
Increase in the prevalence of multiple sclerosis over a 17-year period in Osona, Catalonia, Spain.
The Brown Norway opticospinal model of demyelination: Does it mimic multiple sclerosis or neuromyelitis optica?

Pages